Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Blood cancers, Myeloma
Closed
Phase 1/2
This study is for people whose myeloma has come back or continued to get worse after having at least 2 or 3 different types of standard treatment. Standard treatment for myeloma includes:
targeted cancer drugs (biological therapy)
Recruitment start: 5 May 2017
Recruitment end: 17 September 2019
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Rakesh Popat
Autolus Limited
Last reviewed: 2 October 2019
CRUK internal database number: 15037